UnitedHealth Group Files 8-K Report
Ticker: UNH · Form: 8-K · Filed: Sep 8, 2025 · CIK: 731766
| Field | Detail |
|---|---|
| Company | Unitedhealth Group Inc (UNH) |
| Form Type | 8-K |
| Filed Date | Sep 8, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulation-fd
Related Tickers: UNH
TL;DR
UNH filed an 8-K for a Reg FD disclosure on 9/8/25. No specific details yet.
AI Summary
On September 8, 2025, UnitedHealth Group Incorporated filed an 8-K report. The filing primarily serves as a notification of a Regulation FD Disclosure, with no specific financial transactions or material events detailed within the provided text. The report confirms the company's identity and filing details with the SEC.
Why It Matters
This filing indicates UnitedHealth Group is making a disclosure under Regulation FD, which ensures all investors receive the same material information simultaneously. Investors should look for subsequent filings or press releases for the actual content of the disclosure.
Risk Assessment
Risk Level: low — The filing itself is a procedural notification and does not contain information that inherently increases or decreases risk.
Key Players & Entities
- UNITEDHEALTH GROUP INC (company) — Registrant
- 0000731766-25-000245 (filing_id) — Accession Number
- September 8, 2025 (date) — Date of report
- 1-10864 (company_id) — Commission File Number
- 41-1321939 (ein) — I.R.S. Employer Identification No.
FAQ
What is the specific nature of the Regulation FD Disclosure being made by UnitedHealth Group?
The provided text of the 8-K filing does not specify the content of the Regulation FD Disclosure; it only indicates that such a disclosure is being made as of September 8, 2025.
When was this 8-K report filed with the SEC?
The 8-K report was filed as of September 8, 2025.
What is UnitedHealth Group's Commission File Number?
UnitedHealth Group's Commission File Number is 1-10864.
What is the company's I.R.S. Employer Identification Number?
The company's I.R.S. Employer Identification Number is 41-1321939.
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure.
Filing Stats: 1,061 words · 4 min read · ~4 pages · Grade level 17 · Accepted 2025-09-08 07:00:14
Filing Documents
- unh-20250908.htm (8-K) — 33KB
- 0000731766-25-000245.txt ( ) — 193KB
- unh-20250908.xsd (EX-101.SCH) — 3KB
- unh-20250908_def.xml (EX-101.DEF) — 16KB
- unh-20250908_lab.xml (EX-101.LAB) — 29KB
- unh-20250908_pre.xml (EX-101.PRE) — 17KB
- unh-20250908_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. Senior leaders from UnitedHealth Group Incorporated (the "Company") will be meeting with investors and analysts between September 8, 2025 and September 10, 2025, during which the Company intends to reaffirm our adjusted 2025 earnings per share expectations previously disclosed by the Company on July 29, 2025. This outlook incorporates closing the acquisition of Amedisys in August 2025, which is expected to be modestly dilutive to adjusted earnings per share due to financing costs and the integration related investments. The meetings may also include discussion of the Company's strategy, market positions and recent results, as previously disclosed. The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
Forward-Looking Statements
Forward-Looking Statements The statements, estimates, projections, guidance or outlook contained in this report include "forward-looking" statements which are intended to take advantage of the "safe harbor" provisions of the federal securities laws. The words "believe," "expect," "intend," "estimate," "anticipate," "forecast," "outlook," "plan," "project," "should" and similar expressions identify forward-looking statements. These statements may contain information about financial prospects, economic conditions and trends and involve risks and uncertainties. Actual results could differ materially from those that management expects, depending on the outcome of certain factors including: our ability to effectively estimate, price for and manage medical costs; new or changes in existing health care laws or regulations, or their enforcement or application; cyberattacks, other privacy/data security incidents, or our failure to comply with related regulations; reductions in revenue or delays to cash flows received under government programs; changes in Medicare, the CMS star ratings program or the application of risk adjustment data validation audits; the DOJ's legal actions concerning our participation in the Medicare program; our ability to maintain and achieve improvement in quality scores impacting revenue; failure to maintain effective and efficient information systems or if our technology products do not operate as intended; risks and uncertainties associated with our businesses providing pharmacy care services; competitive pressures, including our ability to maintain or increase our market share; changes in or challenges to our public sector contract awards; failure to achieve targeted operating cost productivity improvements; failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals and other service providers; the impact of potential changes in tax laws and regulations; increases in costs and other liabilities asso
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 8, 2025 UNITEDHEALTH GROUP INCORPORATED By: /s/ Kuai H. Leong Kuai H. Leong Senior Deputy General Counsel and Deputy Corporate Secretary